TMC outlines Q4 2027 production target with U.S. permitting progress and Brownsville hub plans (NASDAQ:TMC)March 27, 2026
Share Facebook Twitter LinkedIn Pinterest Email FDA accepts Adaptimmune BLA for afami-cel, decision expected by Aug. 4
TMC outlines Q4 2027 production target with U.S. permitting progress and Brownsville hub plans (NASDAQ:TMC)March 27, 2026
SANUWAVE outlines 16–25% revenue growth target for 2026 as reseller expansion accelerates (NASDAQ:SNWV)March 27, 2026
